A culture of fear in Lander’s White House science office; scientists eye a wily protein to make immunotherapy more effective

When staffers in Lander's office thought of the adjectives that described their workplace, three words stood out: hostile, siloed, and aggressive. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Inside the culture of fear in Eric Lander's White House science office By Lev Facher Photo illustration: Alex Hogan/STAT; Source: Getty When staffers in Lander’s office thought of the adjectives that described their work environment, three words stood out: hostile, siloed, and aggressive. Read More STAT+: In a wily protein that helps cancer spread, researchers see a chance to make immunotherapy more effective By Angus Chen Molly Ferguson for STAT Here’s STAT’s comprehensive guide to TGF-beta, which biopharma companies are trying to target to make cancer immunotherapy more effective. Read More STAT+: Pfizer criticized over patent strategy for Covid-19 pill, despite a deal to broaden access in poor countries By Ed Silverman Pfizer "Pfizer tried to save the day with its MPP license and created a narrative about sharing technology," said Burcu Kilic of Public Citizen. Read More Sponsor content by STAT Events You're invited to the CRISPR Quest Intellia Therapeutics CEO John Leonard takes the stage on Feb. 24 to discuss what's next for the company now that it’s published data showing that CRISPR could be used in the body to combat disease. Sign up now to join this discussion. Listen: Robert Califf's FDA return, the future of CRISPR, & another vaccine delay By Damian Garde and Meg Tirrell and Adam Feuerstein STAT's Nicholas Florko joins us this episode to preview the trials ahead for Robert Califf as he retakes the reins at the FDA. Read More Opinion: Nonprofit hospitals' community benefits should square with their tax exemptions. They often don't By Ge Bai and David A. Hyman David Goldman/AP To earn tax exemptions, community benefits provided by nonprofit hospitals should exceed those of for-profit hospitals. They often don't. Read More Opinion: Pharma in 2022: Building trust and extending collaboration By Ramona Sequeira Frank Augstein/AP Listening more closely, working more collaboratively, and setting clear priorities are keys for continued success in the pharma industry. Read More Thursday, February 17, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser